维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

8篇 您的检索式：作者名="FRIEDEMANN C"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Cardiovascular disease risk in healthy childrenand its association with body mass index : sys-tematic review and meta-analysis 显示文摘	Friedemann C Heneghan C Mahtani K	2012	BMJ2012，345，：	1
	2	Stem cell-likeplasticity of naive and distinct memory CD8 + T cell subsets 显示文摘	Stemberger C Neuenhahn M Friedemann E	2009	Seminars in Immunology2009，21，2：	1
	3	Cardiovas- cular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis 显示文摘	FRIEDEMANN C HENEGHAN C MAHTANI K	2012	BMJ2012，345，：	1
	4	Cardiovascular disease risk in healthy children and its association with body mass index:systematic review and meta-analysis显示文摘	Friedemann C Heneghan C Mahtani K		0，，：	1
	5	Cardiovas-cular disease risk in healthy children and its association with bodymass index : Sytematic review and meta-analysis显示文摘	FRIEDEMANN C HENEGHAN C MAHTANI K	2012	BMJ2012，345，2：	1
	6	Cardiovascular dis- ease risk in healthy children and its association with body mass in- dex : systematic review and meta-analysis 显示文摘	Friedemann C Heneghan C Mahtani K	2012	BMJ2012，，345：	1
	7	Stem cell-likeplasticity of naive and distinct memory CD8 + T cell subsets 显示文摘	Stemberger C Neuenhahn M Friedemann E	2009	Seminars in Immunology2009，21，2：	1
	8	Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferonβ 1a显示文摘To alert clinicians to a potential novel adverse drug effect of interferonβ 1a,we herein report a patient with relapsing-remitting multiple sclerosis who developed ulcerative colitis following treatment with interferonβ 1a. Ulcerative colitis persisted despite discontinuation of interferonβ 1a treatment and switching the patient to glatiramer acetate. Tacrolimus (FK506),6-mercaptopurine,and prednisolone were required to induce remission. Both ulcerative colitis and multiple sclerosis were eventually well controlled using this regimen. Our report underscores that caution should be exercised when prescribing immunostimulatory agents in patients with inflammatory bowel disease (IBD) and challenges current efforts to stimulate innate immunity as a novel therapeutic concept for IBD.	Eckart Schott Friedemann Paul Jens T Wuerfel Frauke Zipp Birgit Rudolph Bertram Wiedenmann Daniel C Baumgart	2007	World Journal of Gastroenterology2007，13，26：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费